Our new website is coming soon, give it a try now and let us have your feedback. Take me to the Beta



Register
Login:
Share:
Email Facebook Twitter


TSX Lithium explorer International Lithium Corp prepares to drill at Raleigh Lake
Exclusive: Hardman & Co Investor Forum - Severn Trent, Calculus Capital, Volta Finance, Residential
Latest Share Chat



Glaxosmithkline Share Chat (GSK)



Share Price: 1,605.00Bid: 1,605.40Ask: 1,606.00Change: 0.00 (0.00%)No Movement on Glaxosmithkline
Spread: 0.60Spread as %: 0.04%Open: 1,607.40High: 1,608.60Low: 1,587.20Yesterday’s Close: 1,605.00


Share Discussion for Glaxosmithkline


Thread View

Please login or register to post a message on Share Chat.

Posts per page:

riolto10
Posts: 1,941
Opinion:No Opinion
Price:1,595.20
RE: SP
Tue 17:08
Big drop at the end of day. Seems to be the affect of the American market !
 
Exoplanet
Posts: 40
Opinion:No Opinion
Price:1,600.00
RE: SP
Tue 15:15
yep..over £16 and the usual nose bleed, however a close over today, hopefully we can push on...and about time too!
iknowverylittle
Posts: 478
Opinion:No Opinion
Price:1,603.80
RE: SP
Tue 11:21
This is usually the top of the range before it drops back down again.... Hope your right though.
riolto10
Posts: 1,941
Opinion:No Opinion
Price:1,598.60
SP
Tue 09:25
Back over sixteen pounds now the hope is for a steady increase past this resistance leval
eviking
Posts: 2,406
Opinion:No Opinion
Price:1,588.40
RE: presentation
Mon 18:42
Thanks.
ShareSocUK
Posts: 282
Opinion:No Opinion
Price:1,586.80
presentation
Mon 15:46
The GSK presentation from our company visit on the 5th June is available to view in our members area here. Exclusive to full members: hTTps://sharesoc.ning.com/xn/detail/6389471:Comment:53171
Jatw
Posts: 58
Opinion:No Opinion
Price:1,584.40
RE: Forward price
Fri 17:43
History might tell you otherwise as the SP has been 12-16 for a long long time.....24 is adding nearly 40bn in value which is not very likely....SP will only rise when it looks likely the divi can be raised safely and steadily.
Seaking1
Posts: 323
Opinion:No Opinion
Price:1,586.60
Forward price
Fri 15:04
In my opinion the sp will look very cheap in about 18 months time . With all that’s happening with R and D and new products plus recent changes I can see Glaxo rising to about £24 in Normal market conditions. Very strong company.
till then I will keep reinvesting my divi.
johnpwh
Posts: 1,358
Opinion:No Opinion
Price:1,593.00
I'm Out
13 Jun '19
Probably a mistake but made enough in a couple of weeks to pay for my D Day visit, so happy. I don't know the company well enough to comfortably hold. Best of luck to all holders
Dinoken
Posts: 783
Opinion:No Opinion
Price:1,581.40
RE: RE:GSK
11 Jun '19
Keep the consumer side. It won't last long. Will probably have been taken over before its had a chance to pay any divis…

In meantime, looks like GSK will shortly be sweet 16 again.
Gerry557
Posts: 3,981
Opinion:No Opinion
Price:1,582.20
RE: RE:GSK
11 Jun '19
Gerry557, if GSk split, surely the share price can't perform as badly?

Well the stronger part might do better than the weaker part ...... until things change and the stringer part has a downturn. With no support it might not be good.

If it did split there might be calls to do a merger .... and the cycle continues. It seems a lot of effort thats not likely to prove much. Why cant the two halves just improve whilst reporting to one boss. What about the synergies, all those cost cuttings companies do when doing deals to get bigger.

I can see both sides to the argument and both ideas have worked previously but unsure how to value one above the other. As for Divis, its already quarterly and if you want more you can always buy something else. I suppose GSK could go monthly but the overall divi amount would remain the same. Why not just do one big divi instead?

If it splits which half would you keep?
Dinoken
Posts: 783
Opinion:No Opinion
Price:1,563.80
Good Friday
7 Jun '19
Doubly good end to week :
1) Nucala approved by yanks.
2) Stada (German druggie) buying 6 consumer healthcare products from GSK : itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough liquids. GSK streamlining before split.
Exoplanet
Posts: 40
Opinion:No Opinion
Price:1,556.00
RE:GSK
7 Jun '19
Gerry557, if GSk split, surely the share price can't perform as badly? Reminds me of the heady days when Glaxo and smithkline were operating separately, both trading in the high teens and two sets of divis!
Fastforward nearly 20 years ....someone pass me the antidepressants
Gerry557
Posts: 3,981
Opinion:No Opinion
Price:1,556.20
RE: GSK
7 Jun '19
Just checked the HL website and its not there although maybe that is because its suspended rather than swapped for bad performance.
Gerry557
Posts: 3,981
Opinion:No Opinion
Price:1,544.80
GSK
6 Jun '19
Exoplanet, thanks for the link a bit worrying about divi cover lets hope Emma gets a grip.

Pokerchips, maybe she had a vile of something to stab into any wandering hands ...... and if she sold him the antidote we might be quids in.

I wonder if GSK will split, I think its looking like it might. Its what Woody has been calling for all this time till he sold out. Not looking good for him and his fund right now. I wonder if Hargreaves Lansdown still have him in their top 50 funds
Pokerchips
Posts: 7,507
Opinion:No Opinion
Price:1,527.40
Emma and Donald
4 Jun '19
Looks like Emma drew the short straw and ended up having to sit next to Donald Trump at a breakfast meeting with FTSE bosses and the US President

I am sure he couldnt stop himself telling her British medicines from Glaxo were a rip off
Dinoken
Posts: 783
Opinion:No Opinion
Price:1,582.00
RE: Damned aussies ...
26 May '19
Thx AllAtSea - good to know. Nevertheless, think you are being optimistic about buying 2 houses in Chelsea for £3m. You cannot even get a parking space for that.
Good news this week all round for GSK : Shingles approval in China, sales rep incentives re-introduced, and India Competition Committee approval of healthcare tie-up with Pfiser.
AllAtSea
Posts: 919
Opinion:No Opinion
Price:1,549.00
RE: Damned aussies ...
20 May '19
About £3m if ACCC vs Reckitt Benckiser is a guide. That'd buy you nearly two houses in Kensington and Chelsea.
Dinoken
Posts: 783
Opinion:No Opinion
Price:1,555.00
Damned aussies ...
19 May '19
From London South East no less - but I could not find it anywhere on this site. Wonder how much this is going to cost ?

GSK and Novartis have admitted breaching Australian consumer law around Voltaren Osteo Gel and Voltaren Emulgel pain relief products by making "false or misleading representations in the marketing" of the two products.

From January 2012 to March 2017, the companies marketed Osteo Gel as a more effective treatment for pain and inflammation caused by osteoarthritis than Emulgel. In fact, the two medications are "essentially the same".

A later hearing will take place to "determine penalties sought by the ACCC".
Stocktaker01
Posts: 1,391
Opinion:No Opinion
Price:1,547.20
Sale of cork facility
16 May '19
To thermofisher propping this up today.
DOGSINBRAZIL
Posts: 257
Opinion:Strong Buy
Price:1,539.00
RE: Yippie
16 May '19
Yeah investors are piling in a few trail results that are due this summer brokers are starting to get bullish on GSK for frist time in years P.E of 13 dividend soild lot s going on in the Labs things are looking good about time
riolto10
Posts: 1,941
Opinion:No Opinion
Price:1,540.00
RE: Yippie
16 May '19
Equivalent to a 25p rise today!
Seaking1
Posts: 323
Opinion:No Opinion
Price:1,540.60
Yippie
16 May '19
Sold at a profit and also got div, I was expecting a fall.
AllAtSea
Posts: 919
Opinion:No Opinion
Price:1,541.20
RE: safe haven with a good dividend,
16 May '19
Should have gone down really.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk







Home  |  Contact Us  |  About Us  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy  |  Mobile Site  |  About this website design


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.